APO Research
Talk to an analyst

APO RESEARCH · REPORT

Piroxicam API

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Piroxicam API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025191 pages

Choose your research edition.

Industry ResearchPiroxicam API Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Piroxicam API Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Piroxicam API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Piroxicam API Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Piroxicam API Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Piroxicam API market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Piroxicam API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Piroxicam API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Piroxicam API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Piroxicam API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Piroxicam API include Nostrum, SK Chemicals, Pidi Pharmaceutical, Pfizer, Jumpcan Pharmaceutical, Jiangxi Pharmaceutical, Mylan, Maoxiang Pharmaceutical and Teva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Piroxicam API market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Piroxicam API and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Piroxicam API sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Piroxicam API market size, projected growth trends, production technologies, key applications, and end-use industries.

Piroxicam API Segment by Company

Nostrum

SK Chemicals

Pidi Pharmaceutical

Pfizer

Jumpcan Pharmaceutical

Jiangxi Pharmaceutical

Mylan

Maoxiang Pharmaceutical

Teva

Viwit Pharmaceutical

XinAn Pharmaceutical

Changjiang Pharmaceutical

Piroxicam API Segment by Type

Purity≥ 99%

Purity≥ 99.5%

Piroxicam API Segment by Application

Injection

Ointment

Tablets

Capsule

Piroxicam API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Piroxicam API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Piroxicam API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Piroxicam API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Piroxicam API market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Piroxicam API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Piroxicam API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Piroxicam API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Piroxicam API Industry Trends Table 2. Piroxicam API Industry Drivers Table 3. Piroxicam API Industry Opportunities and Challenges Table 4. Piroxicam API Industry Restraints Table 5. Global Piroxicam API Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Piroxicam API Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Piroxicam API Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Piroxicam API Sales Market Share by Manufacturers Table 9. Global Piroxicam API Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Piroxicam API Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Piroxicam API Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Piroxicam API Manufacturers, Product Type & Application Table 13. Global Piroxicam API Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Piroxicam API by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Purity≥ 99% Table 17. Major Manufacturers of Purity≥ 99.5% Table 18. Global Piroxicam API Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Piroxicam API Sales by Type (2021-2026) & (k units) Table 20. Global Piroxicam API Sales by Type (2027-2032) & (k units) Table 21. Global Piroxicam API Sales Market Share by Type (2021-2026) Table 22. Global Piroxicam API Sales Market Share by Type (2027-2032) Table 23. Global Piroxicam API Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Piroxicam API Revenue by Type (2021-2026) & (k units) Table 25. Global Piroxicam API Revenue by Type (2027-2032) & (k units) Table 26. Global Piroxicam API Revenue Market Share by Type (2021-2026) Table 27. Global Piroxicam API Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Injection Table 29. Major Manufacturers of Ointment Table 30. Major Manufacturers of Tablets Table 31. Major Manufacturers of Capsule Table 32. Global Piroxicam API Sales by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Piroxicam API Sales by Application (2021-2026) & (k units) Table 34. Global Piroxicam API Sales by Application (2027-2032) & (k units) Table 35. Global Piroxicam API Sales Market Share by Application (2021-2026) Table 36. Global Piroxicam API Sales Market Share by Application (2027-2032) Table 37. Global Piroxicam API Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global Piroxicam API Revenue by Application (2021-2026) & (k units) Table 39. Global Piroxicam API Revenue by Application (2027-2032) & (k units) Table 40. Global Piroxicam API Revenue Market Share by Application (2021-2026) Table 41. Global Piroxicam API Revenue Market Share by Application (2027-2032) Table 42. Global Piroxicam API Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Piroxicam API Sales by Region (2021-2026) & (k units) Table 44. Global Piroxicam API Sales Market Share by Region (2021-2026) Table 45. Global Piroxicam API Sales Forecasted by Region (2027-2032) & (k units) Table 46. Global Piroxicam API Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Piroxicam API Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 48. North America Piroxicam API Sales by Country (2021-2026) & (k units) Table 49. North America Piroxicam API Sales by Country (2027-2032) & (k units) Table 50. Europe Piroxicam API Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. Europe Piroxicam API Sales by Country (2021-2026) & (k units) Table 52. Europe Piroxicam API Sales by Country (2027-2032) & (k units) Table 53. Asia Pacific Piroxicam API Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Asia Pacific Piroxicam API Sales by Country (2021-2026) & (k units) Table 55. Asia Pacific Piroxicam API Sales by Country (2027-2032) & (k units) Table 56. South America, Middle East and Africa Piroxicam API Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. South America, Middle East and Africa Piroxicam API Sales by Country (2021-2026) & (k units) Table 58. South America, Middle East and Africa Piroxicam API Sales by Country (2027-2032) & (k units) Table 59. Global Piroxicam API Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Piroxicam API Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Piroxicam API Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Piroxicam API Revenue Market Share by Region (2021-2026) Table 63. Global Piroxicam API Revenue Market Share by Region (2027-2032) Table 64. Nostrum Company Information Table 65. Nostrum Business Overview Table 66. Nostrum Piroxicam API Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Nostrum Piroxicam API Product Portfolio Table 68. Nostrum Recent Development Table 69. SK Chemicals Company Information Table 70. SK Chemicals Business Overview Table 71. SK Chemicals Piroxicam API Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. SK Chemicals Piroxicam API Product Portfolio Table 73. SK Chemicals Recent Development Table 74. Pidi Pharmaceutical Company Information Table 75. Pidi Pharmaceutical Business Overview Table 76. Pidi Pharmaceutical Piroxicam API Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Pidi Pharmaceutical Piroxicam API Product Portfolio Table 78. Pidi Pharmaceutical Recent Development Table 79. Pfizer Company Information Table 80. Pfizer Business Overview Table 81. Pfizer Piroxicam API Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Pfizer Piroxicam API Product Portfolio Table 83. Pfizer Recent Development Table 84. Jumpcan Pharmaceutical Company Information Table 85. Jumpcan Pharmaceutical Business Overview Table 86. Jumpcan Pharmaceutical Piroxicam API Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Jumpcan Pharmaceutical Piroxicam API Product Portfolio Table 88. Jumpcan Pharmaceutical Recent Development Table 89. Jiangxi Pharmaceutical Company Information Table 90. Jiangxi Pharmaceutical Business Overview Table 91. Jiangxi Pharmaceutical Piroxicam API Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Jiangxi Pharmaceutical Piroxicam API Product Portfolio Table 93. Jiangxi Pharmaceutical Recent Development Table 94. Mylan Company Information Table 95. Mylan Business Overview Table 96. Mylan Piroxicam API Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Mylan Piroxicam API Product Portfolio Table 98. Mylan Recent Development Table 99. Maoxiang Pharmaceutical Company Information Table 100. Maoxiang Pharmaceutical Business Overview Table 101. Maoxiang Pharmaceutical Piroxicam API Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Maoxiang Pharmaceutical Piroxicam API Product Portfolio Table 103. Maoxiang Pharmaceutical Recent Development Table 104. Teva Company Information Table 105. Teva Business Overview Table 106. Teva Piroxicam API Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Teva Piroxicam API Product Portfolio Table 108. Teva Recent Development Table 109. Viwit Pharmaceutical Company Information Table 110. Viwit Pharmaceutical Business Overview Table 111. Viwit Pharmaceutical Piroxicam API Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Viwit Pharmaceutical Piroxicam API Product Portfolio Table 113. Viwit Pharmaceutical Recent Development Table 114. XinAn Pharmaceutical Company Information Table 115. XinAn Pharmaceutical Business Overview Table 116. XinAn Pharmaceutical Piroxicam API Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. XinAn Pharmaceutical Piroxicam API Product Portfolio Table 118. XinAn Pharmaceutical Recent Development Table 119. Changjiang Pharmaceutical Company Information Table 120. Changjiang Pharmaceutical Business Overview Table 121. Changjiang Pharmaceutical Piroxicam API Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Changjiang Pharmaceutical Piroxicam API Product Portfolio Table 123. Changjiang Pharmaceutical Recent Development Table 124. Key Raw Materials Table 125. Raw Materials Key Suppliers Table 126. Piroxicam API Distributors List Table 127. Piroxicam API Customers List Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Piroxicam API Product Image Figure 2. Global Piroxicam API Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Piroxicam API Market Size (2021-2032) & (US$ Million) Figure 4. Global Piroxicam API Sales (2021-2032) & (k units) Figure 5. Global Piroxicam API Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Piroxicam API Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Purity≥ 99% Image Figure 9. Purity≥ 99.5% Image Figure 10. Global Piroxicam API Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Piroxicam API Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Piroxicam API Sales Market Share by Type (2021-2032) Figure 13. Global Piroxicam API Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Piroxicam API Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Piroxicam API Revenue Market Share by Type (2021-2032) Figure 16. Injection Image Figure 17. Ointment Image Figure 18. Tablets Image Figure 19. Capsule Image Figure 20. Global Piroxicam API Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Piroxicam API Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Piroxicam API Sales Market Share by Application (2021-2032) Figure 23. Global Piroxicam API Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Piroxicam API Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Piroxicam API Revenue Market Share by Application (2021-2032) Figure 26. North America Piroxicam API Sales and Growth Rate (2021-2032) & (k units) Figure 27. North America Piroxicam API Sales Market Share by Country (2021-2032) Figure 28. U.S. Piroxicam API Sales and Growth Rate (2021-2032) & (k units) Figure 29. Canada Piroxicam API Sales and Growth Rate (2021-2032) & (k units) Figure 30. Mexico Piroxicam API Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Piroxicam API Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Piroxicam API Sales Market Share by Country (2021-2032) Figure 33. Germany Piroxicam API Sales and Growth Rate (2021-2032) & (k units) Figure 34. France Piroxicam API Sales and Growth Rate (2021-2032) & (k units) Figure 35. U.K. Piroxicam API Sales and Growth Rate (2021-2032) & (k units) Figure 36. Italy Piroxicam API Sales and Growth Rate (2021-2032) & (k units) Figure 37. Netherlands Piroxicam API Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Piroxicam API Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Piroxicam API Sales Market Share by Country (2021-2032) Figure 40. China Piroxicam API Sales and Growth Rate (2021-2032) & (k units) Figure 41. Japan Piroxicam API Sales and Growth Rate (2021-2032) & (k units) Figure 42. South Korea Piroxicam API Sales and Growth Rate (2021-2032) & (k units) Figure 43. Southeast Asia Piroxicam API Sales and Growth Rate (2021-2032) & (k units) Figure 44. India Piroxicam API Sales and Growth Rate (2021-2032) & (k units) Figure 45. Australia Piroxicam API Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Piroxicam API Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Piroxicam API Sales Market Share by Country (2021-2032) Figure 48. Brazil Piroxicam API Sales and Growth Rate (2021-2032) & (k units) Figure 49. South Africa Piroxicam API Sales and Growth Rate (2021-2032) & (k units) Figure 50. Saudi Arabia Piroxicam API Sales and Growth Rate (2021-2032) & (k units) Figure 51. Turkey Piroxicam API Sales and Growth Rate (2021-2032) & (k units) Figure 52. Argentina Piroxicam API Sales and Growth Rate (2021-2032) & (k units) Figure 53. UAE Piroxicam API Sales and Growth Rate (2021-2032) & (k units) Figure 54. Egypt Piroxicam API Sales and Growth Rate (2021-2032) & (k units) Figure 55. Chile Piroxicam API Sales and Growth Rate (2021-2032) & (k units) Figure 56. Global Piroxicam API Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Piroxicam API Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Piroxicam API Revenue (2021-2032) & (US$ Million) Figure 59. North America Piroxicam API Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Piroxicam API Revenue (2021-2032) & (US$ Million) Figure 61. Europe Piroxicam API Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Piroxicam API Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Piroxicam API Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Piroxicam API Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Piroxicam API Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Piroxicam API Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Piroxicam API Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Purity≥ 99%
  • Purity≥ 99.5%
Applications
  • Injection
  • Ointment
  • Tablets
  • Capsule
Companies covered
  • Nostrum
  • SK Chemicals
  • Pidi Pharmaceutical
  • Pfizer
  • Jumpcan Pharmaceutical
  • Jiangxi Pharmaceutical
  • Mylan
  • Maoxiang Pharmaceutical
  • Teva
  • Viwit Pharmaceutical
  • XinAn Pharmaceutical
  • Changjiang Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Piroxicam API Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Piroxicam API Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Piroxicam API Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Piroxicam API Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Piroxicam API Market Dynamics
  1. 2.1 Piroxicam API Industry Trends
  2. 2.2 Piroxicam API Industry Drivers
  3. 2.3 Piroxicam API Industry Opportunities and Challenges
  4. 2.4 Piroxicam API Industry Restraints
3 Piroxicam API Market by Manufacturers
  1. 3.1 Global Piroxicam API Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Piroxicam API Sales by Manufacturers (2021-2026)
  3. 3.3 Global Piroxicam API Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Piroxicam API Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Piroxicam API Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Piroxicam API Manufacturers, Product Type & Application
  7. 3.7 Global Piroxicam API Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Piroxicam API Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Piroxicam API Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Piroxicam API Tier 1, Tier 2, and Tier 3
4 Piroxicam API Market by Type
  1. 4.1 Piroxicam API Type Introduction
  2. 4.1.1 Purity≥ 99%
  3. 4.1.2 Purity≥ 99.5%
  4. 4.2 Global Piroxicam API Sales by Type
  5. 4.2.1 Global Piroxicam API Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Piroxicam API Sales by Type (2021-2032)
  7. 4.2.3 Global Piroxicam API Sales Market Share by Type (2021-2032)
  8. 4.3 Global Piroxicam API Revenue by Type
  9. 4.3.1 Global Piroxicam API Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Piroxicam API Revenue by Type (2021-2032)
  11. 4.3.3 Global Piroxicam API Revenue Market Share by Type (2021-2032)
5 Piroxicam API Market by Application
  1. 5.1 Piroxicam API Application Introduction
  2. 5.1.1 Injection
  3. 5.1.2 Ointment
  4. 5.1.3 Tablets
  5. 5.1.4 Capsule
  6. 5.2 Global Piroxicam API Sales by Application
  7. 5.2.1 Global Piroxicam API Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Piroxicam API Sales by Application (2021-2032)
  9. 5.2.3 Global Piroxicam API Sales Market Share by Application (2021-2032)
  10. 5.3 Global Piroxicam API Revenue by Application
  11. 5.3.1 Global Piroxicam API Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Piroxicam API Revenue by Application (2021-2032)
  13. 5.3.3 Global Piroxicam API Revenue Market Share by Application (2021-2032)
6 Global Piroxicam API Sales by Region
  1. 6.1 Global Piroxicam API Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Piroxicam API Sales by Region (2021-2032)
  3. 6.2.1 Global Piroxicam API Sales by Region (2021-2026)
  4. 6.2.2 Global Piroxicam API Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Piroxicam API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Piroxicam API Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Piroxicam API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Piroxicam API Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Piroxicam API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Piroxicam API Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Piroxicam API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Piroxicam API Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Piroxicam API Revenue by Region
  1. 7.1 Global Piroxicam API Revenue by Region
  2. 7.1.1 Global Piroxicam API Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Piroxicam API Revenue by Region (2021-2026)
  4. 7.1.3 Global Piroxicam API Revenue by Region (2027-2032)
  5. 7.1.4 Global Piroxicam API Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Piroxicam API Revenue (2021-2032)
  8. 7.2.2 North America Piroxicam API Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Piroxicam API Revenue (2021-2032)
  11. 7.3.2 Europe Piroxicam API Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Piroxicam API Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Piroxicam API Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Piroxicam API Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Piroxicam API Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Nostrum
  2. 8.1.1 Nostrum Company Information
  3. 8.1.2 Nostrum Business Overview
  4. 8.1.3 Nostrum Piroxicam API Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Nostrum Piroxicam API Product Portfolio
  6. 8.1.5 Nostrum Recent Developments
  7. 8.2 SK Chemicals
  8. 8.2.1 SK Chemicals Company Information
  9. 8.2.2 SK Chemicals Business Overview
  10. 8.2.3 SK Chemicals Piroxicam API Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 SK Chemicals Piroxicam API Product Portfolio
  12. 8.2.5 SK Chemicals Recent Developments
  13. 8.3 Pidi Pharmaceutical
  14. 8.3.1 Pidi Pharmaceutical Company Information
  15. 8.3.2 Pidi Pharmaceutical Business Overview
  16. 8.3.3 Pidi Pharmaceutical Piroxicam API Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pidi Pharmaceutical Piroxicam API Product Portfolio
  18. 8.3.5 Pidi Pharmaceutical Recent Developments
  19. 8.4 Pfizer
  20. 8.4.1 Pfizer Company Information
  21. 8.4.2 Pfizer Business Overview
  22. 8.4.3 Pfizer Piroxicam API Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Piroxicam API Product Portfolio
  24. 8.4.5 Pfizer Recent Developments
  25. 8.5 Jumpcan Pharmaceutical
  26. 8.5.1 Jumpcan Pharmaceutical Company Information
  27. 8.5.2 Jumpcan Pharmaceutical Business Overview
  28. 8.5.3 Jumpcan Pharmaceutical Piroxicam API Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Jumpcan Pharmaceutical Piroxicam API Product Portfolio
  30. 8.5.5 Jumpcan Pharmaceutical Recent Developments
  31. 8.6 Jiangxi Pharmaceutical
  32. 8.6.1 Jiangxi Pharmaceutical Company Information
  33. 8.6.2 Jiangxi Pharmaceutical Business Overview
  34. 8.6.3 Jiangxi Pharmaceutical Piroxicam API Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Jiangxi Pharmaceutical Piroxicam API Product Portfolio
  36. 8.6.5 Jiangxi Pharmaceutical Recent Developments
  37. 8.7 Mylan
  38. 8.7.1 Mylan Company Information
  39. 8.7.2 Mylan Business Overview
  40. 8.7.3 Mylan Piroxicam API Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Mylan Piroxicam API Product Portfolio
  42. 8.7.5 Mylan Recent Developments
  43. 8.8 Maoxiang Pharmaceutical
  44. 8.8.1 Maoxiang Pharmaceutical Company Information
  45. 8.8.2 Maoxiang Pharmaceutical Business Overview
  46. 8.8.3 Maoxiang Pharmaceutical Piroxicam API Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Maoxiang Pharmaceutical Piroxicam API Product Portfolio
  48. 8.8.5 Maoxiang Pharmaceutical Recent Developments
  49. 8.9 Teva
  50. 8.9.1 Teva Company Information
  51. 8.9.2 Teva Business Overview
  52. 8.9.3 Teva Piroxicam API Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Teva Piroxicam API Product Portfolio
  54. 8.9.5 Teva Recent Developments
  55. 8.10 Viwit Pharmaceutical
  56. 8.10.1 Viwit Pharmaceutical Company Information
  57. 8.10.2 Viwit Pharmaceutical Business Overview
  58. 8.10.3 Viwit Pharmaceutical Piroxicam API Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Viwit Pharmaceutical Piroxicam API Product Portfolio
  60. 8.10.5 Viwit Pharmaceutical Recent Developments
  61. 8.11 XinAn Pharmaceutical
  62. 8.11.1 XinAn Pharmaceutical Company Information
  63. 8.11.2 XinAn Pharmaceutical Business Overview
  64. 8.11.3 XinAn Pharmaceutical Piroxicam API Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 XinAn Pharmaceutical Piroxicam API Product Portfolio
  66. 8.11.5 XinAn Pharmaceutical Recent Developments
  67. 8.12 Changjiang Pharmaceutical
  68. 8.12.1 Changjiang Pharmaceutical Company Information
  69. 8.12.2 Changjiang Pharmaceutical Business Overview
  70. 8.12.3 Changjiang Pharmaceutical Piroxicam API Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Changjiang Pharmaceutical Piroxicam API Product Portfolio
  72. 8.12.5 Changjiang Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Piroxicam API Value Chain Analysis
  2. 9.1.1 Piroxicam API Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Piroxicam API Production Mode & Process
  6. 9.2 Piroxicam API Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Piroxicam API Distributors
  9. 9.2.3 Piroxicam API Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst